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Abstract
Background: There is evidence for a positive relationship between cigarette and coffee
consumption in smokers. Cigarette smoke increases metabolism of caffeine, so this may
represent a causal effect of smoking on caffeine intake.
Methods: We performed Mendelian randomization analyses in the UK Biobank
(N¼ 114 029), the Norwegian HUNT study (N¼56 664) and the Copenhagen General
Population Study (CGPS) (N¼78 650). We used the rs16969968 genetic variant as a proxy
for smoking heaviness in all studies and rs4410790 and rs2472297 as proxies for coffee
consumption in UK Biobank and CGPS. Analyses were conducted using linear regression
and meta-analysed across studies.
Results: Each additional cigarette per day consumed by current smokers was associated
with higher coffee consumption (0.10 cups per day, 95% CI: 0.03, 0.17). There was weak
evidence for an increase in tea consumption per additional cigarette smoked per day
(0.04 cups per day, 95% CI: 0.002, 0.07). There was strong evidence that each additional
copy of the minor allele of rs16969968 (which increases daily cigarette consumption) in
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current smokers was associated with higher coffee consumption (0.16 cups per day, 95%
CI: 0.11, 0.20), but only weak evidence for an association with tea consumption (0.04
cups per day, 95% CI: -0.01, 0.09). There was no clear evidence that rs16969968 was asso-
ciated with coffee or tea consumption in never or former smokers or that the coffee-
related variants were associated with cigarette consumption.
Conclusions: Higher cigarette consumption causally increases coffee intake. This is con-
sistent with faster metabolism of caffeine by smokers, but could also reflect a behav-
ioural effect of smoking on coffee drinking.
Key words: Coffee, tea, smoking, Mendelian randomization
Introduction
Smoking and coffee consumption have been shown to be
strongly positively associated; smokers consume more cof-
fee than non-smokers and, within smokers, smoking heavi-
ness is associated with higher coffee consumption.1
Whether this relationship is specific to coffee, or extends to
other caffeinated beverages, is less clear; however, a recent
analysis in a UK cohort found a similar positive relation-
ship with tea, suggesting it could apply more generally to
caffeine.2
Given the known harmful effects of smoking and the
widespread interest in the health effects of coffee or caf-
feine, which have been implicated (often as a protective
factor) in a number of diseases including cancer, depres-
sion and diabetes,3–7 it is important to understand what
drives this association. Cigarette smoking induces the cyto-
chrome P450 1A2 (CYP1A2) enzyme, which is the primary
enzyme involved in caffeine metabolism, and experimen-
tally smoking decreases levels of plasma caffeine.8–12
Therefore, accelerated elimination of caffeine by tobacco
smoking may lead to increased caffeine tolerance and cof-
fee consumption.13 There may also be behavioural associ-
ations, as cigarettes and coffee are often consumed
together. However, there are few data on whether smoking
leads to increased coffee or caffeine consumption at the
population level. Inferring causality from observational
studies is difficult, due to the problems of confounding (by
unmeasured or poorly measured factors) and reverse
causality.
One potential way to minimize these problems is to use
genetic variants which are associated with exposures as
proxies for measured exposures in a Mendelian random-
ization analysis.14,15 A single nucleotide polymorphism,
rs16969968 in the CHRNA5 nicotinic receptor subunit
gene, influences smoking heaviness (or tobacco consump-
tion) within smokers.16 Each additional copy of the minor
allele of rs16969968 (or its proxy, rs1051730) is robustly
associated with smoking, on average, one additional cigar-
ette per day.17,18 Genetic variants have also been identified
which robustly associate with coffee consumption, with
the two most strongly associated loci located between the
CYP1A1/2 genes (e.g. rs2472297) and near the aryl hydro-
carbon receptor (AHR) gene (e.g. rs4410790).19–21
Of note, the smoking heaviness variant was reported to
be associated with coffee consumption in a coffee con-
sumption genome-wide association study (GWAS), but at
a nominal level of significance and in a sample combining
both smokers and non-smokers.22 A recent Mendelian ran-
domization analysis of smoking and caffeine in a UK study
and in a Dutch study (which did stratify into current, for-
mer and never smokers) did not find any evidence for a
causal effect of smoking on caffeine intake or for a causal
effect of caffeine intake on smoking.23 However, the sam-
ple sizes used were modest, so it is likely that these analyses
were underpowered. A recent analysis of the association of
coffee-related genetic variants with daily cigarette con-
sumption including data from UK Biobank did not support
a causal effect of coffee consumption on increased cigarette
Key Messages
• Heavier smoking causes increased coffee consumption.
• This finding is strengthened by its consistency across three studies from the UK, Norway and Denmark with different
patterns of coffee consumption.
• Evidence for a causal effect between smoking and tea consumption is weaker, possibly reflecting lower caffeine
content in tea.
• There is no clear evidence that coffee consumption increases cigarette consumption but this may reflect lower power
to detect an effect.
2 International Journal of Epidemiology, 2017, Vol. 0, No. 0
Downloaded from https://academic.oup.com/ije/advance-article-abstract/doi/10.1093/ije/dyx147/4082629
by Kobenhavns Universitets user
on 04 December 2017
consumption.24 We sought to extend this work by per-
forming a Mendelian randomization analysis to investigate
whether there is a causal effect of smoking on coffee and
tea consumption, in three large studies: the UK Biobank,
the Norwegian HUNT study and the Copenhagen General
Population Study (CGPS). In addition, we performed a
Mendelian randomization analysis to investigate the causal
effect of coffee consumption on cigarette consumption in
the UK Biobank and the CGPS.
Methods
Study populations
We included individuals from three studies: the UK
Biobank, which recruited over 500 000 men and women
(aged 37 to 73 years) between 2006 and 2010,25 the se-
cond wave of the Norwegian HUNT study (1995–97),26
which invited all adults aged 20 years and older in the
county of Nord-Trøndelag to participate, and the
Copenhagen General Population Study (CGPS), a pro-
spective cohort study with ongoing enrolment started in
2003.27 Full details of the study populations, including
participation flowcharts, are available in Supplementary
material (Supplementary Figures S1–S3, available as
Supplementary data at IJE online).
Genotyping
Information on genotyping of rs16969968 (UK Biobank)
and rs1051730 (HUNT and CGPS) and on rs4410790 and
rs2472297 (in UK Biobank and the CGPS) is provided in
Supplementary material, available at IJE online. Coffee-
related single nucleotide polymorphisms (SNPs) were not
available in the HUNT study.
Smoking behaviour
In all studies, smoking status was classified as never
smoker, former smoker, current smoker and ever smoker
(current and former smokers combined). Current smokers
were also asked how many cigarettes they smoked per day.
Full details of how the smoking variables were derived in
each study are available in Supplementary material, avail-
able at IJE online.
Coffee and tea consumption
Coffee and tea consumption were self-reported as the num-
ber of cups consumed daily. Full details of how these vari-
ables were collected in the individual studies are available
in Supplementary material at IJE online. Information on
whether type of coffee consumption was most commonly
caffeinated or decaffeinated was available in UK Biobank,
but not in HUNT or Copenhagen. However, consumption
of decaffeinated coffee in Norway and Denmark is
low.28,29 Information on whether tea consumption was
caffeinated or decaffeinated was not available in any of the
studies.
Covariates
Observational analyses were adjusted for age, sex and edu-
cational attainment. A full description of the covariates
used in each study is provided in Supplementary material,
available at IJE online.
Statistical analysis
Analyses were conducted in Stata (version 14. 1). Within
each study, associations between smoking status (never,
former and current) and smoking heaviness (cigarettes per
day) and continuous measures of coffee and tea were inves-
tigated using linear regression. These analyses were ad-
justed for age, sex and educational attainment. Robust
standard errors were used to account for non-normality of
residuals, as tea and coffee data tended to be right skewed.
We assessed the association between the genotypes
(rs16969968/rs1051730, coded as 0,1,2 according to the
number of smoking heaviness-increasing alleles) and smok-
ing heaviness using linear regression. In UK Biobank and
the CGPS, we created an unweighted genetic risk score
from the two coffee-related SNPs, coded as 0,1,2,3 or 4,
according to the number of coffee consumption-increasing
alleles (major allele for rs4410790 and minor allele for
rs2472297). We assessed the association of this risk score
with coffee consumption in daily smokers using linear
regression.
In Mendelian randomization analysis, we used linear
regression to investigate associations of the smoking
heaviness-related variants with amount of coffee and tea
consumption, and logistic regression to investigate associ-
ations with any compared with no consumption of these
drinks. These analyses were performed stratified by smok-
ing status (never, former, current and ever). As the genetic
variant is only associated with smoking heaviness in indi-
viduals who smoke, we should only see evidence for an as-
sociation with coffee or tea in current smokers (and
perhaps former smokers if the effects are long-lasting). An
association with coffee or tea consumption in never smok-
ers would suggest a pleiotropic effect of the variant (not
acting through cigarette consumption). Associations of the
coffee genetic risk score with daily cigarette consumption
were investigated using linear regression. Genetic analyses
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were adjusted for age, sex (in all studies) and principal gen-
etic components (in UK Biobank only).
All analyses were performed within individual studies
and combined in inverse variance weighted fixed-effect
meta-analyses. We assessed heterogeneity between associ-
ations in the different smoking categories using Cochran’s
Q and the I-squared statistic. When there was evidence of
heterogeneity (I2> 50%), we used a random-effects meta-
analysis. Primary analyses were performed only in individ-
uals who reported consuming coffee or tea, but we also
conducted sensitivity analyses including all individuals
(consumers and non-consumers).
Results
The analysis sample consisted of 114 029 individuals from
UK Biobank, 56 664 individuals from the HUNT study and
78 650 individuals from the Copenhagen General Population
Study (see Table 1). Smoking prevalence was higher in the
HUNT study than in CGPS and UK Biobank. Coffee con-
sumption was more common in the HUNT and CGPS than
in UK Biobank, but tea consumption was more common in
the UK Biobank than in HUNT and CGPS. Among con-
sumers, individuals from the UK Biobank tended to drink
more cups of tea per day, but less cups of coffee per day,
than in HUNT and CGPS. In all studies, there was a negative
correlation between coffee and tea consumption when con-
sidering individuals who consumed at least some tea or cof-
fee (Supplementary Table S1, available as Supplementary
data at IJE online). However, correlations were weaker in in-
dividuals reporting both tea and coffee consumption.
Associations of tea and coffee consumption and
smoking with demographic factors
Similar patterns of smoking with age, sex and education
were observed across the studies (see Supplementary
Tables S2–S4, available as Supplementary data at IJE on-
line). However, there were some differences in patterns of
coffee and tea consumption by demographic factors be-
tween the studies (see Supplementary Tables S5–S7, avail-
able as Supplementary data at IJE online).
Observational associations between smoking and
coffee and tea consumption
In observational analyses of smoking status and smoking
heaviness (cigarettes per day) with coffee and tea
Table 1. Characteristics of the study populations
UK Biobank (114029)b HUNT (56664)b CGPS (78650)b
Mean/N SD/IQR/% Range Mean/N SD/IQR/% Range Mean/N SD/IQR/% Range
Age 56.9 7.9 40–73 49.9 17.1 19–101 57.6 13.1 20–99
Sex
Male 53893 47.3 27021 47.7 35288 55.1
Female 60136 52.7 29643 52.3 43362 44.9
Educational attainmenta
Low 20501 18.1 19759 36.6 17560 22.4
Middle 40829 36.1 23514 43.6 27456 35.0
High 51687 45.7 10653 19.8 33376 42.6
Smoking status
Never 61179 53.7 24747 43.7 32168 40.9
Former 39006 34.2 14350 25.3 31553 40.1
Current 13844 12.1 17528 31.0 14929 19.0
Cigarettes per day current smokers 17.0 8.2 11.2 5.7 15.4 9.1
Tea/coffee consumption
Any tea consumption 96522 84.7 18130 55.7 45789 58.2
Any coffee consumption 89789 78.7 49991 91.0 70228 89.3
Any tea or coffee consumption 111582 97.9 52512 95.0 77023 97.9
Tea consumption (cups per day) in tea drinkers:
median (IQR)
4 2,5 0.5–25 2 1,2 1–21 1.1 0.6, 2.3 0.1–25
Coffee (cups per day) in coffee drinkers:
median (IQR)
2 1,4 0.5–25 5 2,5 1–50 2.9 1.4, 4 0.1–25
aEducation defined as follows. UK Biobank: high: degree/professional qualifications, middle: school/vocational qualifications, low: no qualifications. HUNT:
high: college/university education (> 12 years), middle: secondary education (11–12 years), low: primary education (< 10 years). CGPS: High: university degree,
Middle: college degree, Low: no education/studying/vocational qualifications/short education.
bNumber of participants with genotype information, varies according to missing values on different variables.
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consumption, there was a high degree of heterogeneity
between studies (I2> 95%). Former and current smoking
were associated with higher coffee consumption (Figure 1),
but there was no overall evidence from the meta-analysis
that smoking status was associated with tea consumption.
Among smokers, each additional cigarette smoked per
day was positively associated with both coffee and tea
consumption, although the association was larger for cof-
fee (0.10 cups per day, 95% CI: 0.03, 0.17) than for tea
(0.04 cups per day, 95% CI: -0.002, 0.07) (Figure 2).
Mutual adjustment of associations for tea and coffee
consumption did not make any material difference to re-
sults (see Supplementary Tables S8 and S9, available as
Supplementary data at IJE online).
Mendelian randomization: smoking heaviness to
coffee and tea consumption
In the combined estimate, each additional copy of the
minor allele of rs16969968/rs1051730 was associated
with smoking 0.83 additional cigarettes per day (95% CI:
0.63, 1.03, I2 71%, combined using random-effects
meta-analysis, Supplementary Table S10, available as
Supplementary data at IJE online). There was no clear
consistent evidence that rs16969968/rs1051730 was
associated with sex or education in any of the studies.
When stratified by smoking status, there was some evi-
dence in the UK Biobank that rs16969968/rs1051730
genotype was associated with age (age decreased per
copy of the minor allele) in former and current smokers
Figure 1. Associations between smoking status and tea and coffee consumption. Beta coefficients represent difference in coffee/tea consumption in
former and current compared with never smokers. Analyses adjusted for age, sex and educational attainment. From linear regression using robust
standard errors to account for non-normality of residuals. Estimates combined in a random-effects meta-analysis.
Figure 2. Associations between number of cigarettes per day among current smokers and coffee and tea consumption. Beta coefficients represent
difference in coffee/tea consumption in current smokers per additional cigarette consumed per day. Analyses adjusted for age, sex and educational
attainment. From linear regression using robust standard errors to account for non-normality of residuals. In UK Biobank, N represents number of
current daily smokers only. Estimates combined in a random-effects meta-analysis.
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but not never smokers (see Supplementary Tables S11–
S22, available as Supplementary data at IJE online). This is
consistent with the known effects of this variant on
mortality.30
In the combined estimate from the meta-analysis,
rs16969968/rs1051730 genotype was not associated with
consuming any coffee compared with no coffee, nor with
consuming any coffee or tea compared with no coffee or
tea (see Supplementary Figures S4–S5, available as
Supplementary data at IJE online). However, the minor al-
lele was associated with reduced odds of consuming any
tea compared with no tea consumption (OR: 0.94, 95%
CI: 0.91, 0.97) (see Supplementary Figure S6, available as
Supplementary data at IJE online).
There was strong evidence that the minor allele of
rs16969968/rs1051730 was associated with increased cof-
fee consumption in current smokers (Figure 3). As there
was evidence for heterogeneity between studies in some
smoking groups (former and ever smokers), results from
random effects meta-analyses are presented. Each add-
itional copy of the minor allele was associated with a 0.16-
cup increase in coffee consumption (95% CI: 0.11, 0.20).
There was no clear evidence that rs16969968/rs1051730
was associated with coffee consumption in never smokers
(beta 0.02, 95% CI: -0.003, 0.03) or in former smokers
(beta 0.04, 95% CI: -0.03, 0.10). There was evidence
for heterogeneity between studies in the estimate in for-
mer smokers (I2 85%). Including non-consumers of coffee
in this analysis did not materially change results
(Supplementary Figure S7, available as Supplementary
data at IJE online).
There was no strong evidence for an association be-
tween rs16969968 and tea consumption in any of the
smoking categories (Figure 4). The association was stron-
gest in current smokers [0.04 cups per day per additional
minor allele (95% CI: 0.01, 0.09)]. However, there was
no clear statistical evidence for differences in the associ-
ation between smoking categories (Pheterogeneity¼ 0.22).
Including non-consumers of tea in this analysis weakened
the magnitude of association seen in both current and for-
mer smokers (Supplementary Figure S8, available as
Supplementary data at IJE online).
Given the negative correlation between coffee and tea
consumption, we also performed analyses combining cof-
fee and tea consumption (by adding together cups of tea
and coffee consumed). These results were similar to those
observed for coffee consumption alone (see Supplementary
Figure S9, available as Supplementary data at IJE online).
Among individuals consuming some tea or coffee, there
was evidence that the minor allele was associated with an
increase in the ratio of coffee to tea consumed among ever
smokers (beta 0.04, 95% CI: 0.01, 0.07) but not among
never smokers (beta -0.002, 95% CI: 0.02, 0.02)
(Supplementary Figure S10, available as Supplementary
data at IJE online). Similarly, among individuals consum-
ing different amounts of coffee and tea, the minor allele
was associated with increased odds of drinking more coffee
Figure 3. Associations between rs16969968/rs1051730 and coffee con-
sumption. Adjusted for age, sex (in all studies) and principal compo-
nents (in UK Biobank). Analyses restricted to individuals reporting at
least some coffee consumption. In UK Biobank, ‘current smokers’ in-
cludes daily and occasional current smokers. Estimates combined in a
random-effects meta-analysis.
Never smokers
UK Biobank
HUNT
CGPS
Subtotal  (I-squared = 3.9%, p = 0.353)
Former smokers
UK Biobank
HUNT
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Current smokers
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0.073 (-0.024, 0.169)
0.026 (-0.067, 0.118)
0.034 (-0.042, 0.110)
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ES (95% CI)
0-.2 .2
Change in tea consumption (cups per day) per minor allele
Figure 4. Associations between rs16969968/rs1051730 and tea con-
sumption. Adjusted for age, sex (in all studies) and principal compo-
nents (in UK Biobank). Analyses restricted to individuals reporting at
least some tea consumption. In UK Biobank, ‘current smokers’ includes
daily and occasional current smokers. Estimates combined in a fixed-ef-
fects meta-analysis.
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than tea in current [odds ratio (OR) per minor allele: 1.06,
95% CI: 1.01, 1.10] and ever smokers (OR per minor al-
lele: 1.02, 95% CI: 1.00, 1.05) but not in never smokers
(OR per minor allele: 0.99, 95% CI: 0.97, 1.01)
(Supplementary Figure S11, available as Supplementary
data at IJE online).
Within UK Biobank, data were available on type of cof-
fee most commonly consumed. A similar pattern of results
was obtained for both caffeinated and decaffeinated con-
sumption, although confidence intervals for decaffeinated
coffee consumption were wide (see Supplementary Figure
S12, available as Supplementary data at IJE online). To
test whether associations were limited to caffeinated bever-
ages or reflected a general effect of smoking heaviness on
thirst, we also performed a Mendelian randomization ana-
lysis in UK Biobank with water consumption as the out-
come (Supplementary Figure S13, available as
Supplementary data at IJE online). There was no clear evi-
dence that rs16969968/rs1051730 was associated with
water consumption in any of the smoking categories, al-
though the minor allele was associated with lower water
consumption among current smokers, but the precision of
this estimate was low.
Mendelian randomization: coffee consumption to
smoking heaviness
In current smokers from UK Biobank (N¼10 665) and
CGPS (N¼ 14 929), each coffee consumption-increasing
allele of the genetic risk score was associated with consum-
ing 0.09 additional cups of coffee per day (95% CI:
0.07, 0.12) (Supplementary Table S23, available as
Supplementary data at IJE online). There was no clear evi-
dence for an association between the coffee genetic risk
score and cigarette consumption (age- and sex-adjusted
beta per coffee consumption-increasing allele: -0.01 cig-
arettes per day, 95% CI: -0.07, 0.05). This association
was similar in coffee consumers and non-consumers
(Supplementary Table S24, available as Supplementary
data at IJE online).
Discussion
In three large studies from the UK, Norway and Denmark,
which have different patterns of coffee and tea consump-
tion, we have demonstrated that being a smoker is associ-
ated with higher coffee intake, and that within smokers,
tobacco consumption is positively associated with coffee
consumption. The results from our Mendelian randomiza-
tion analysis of coffee consumption were largely consistent
across studies and provide evidence that heavier smoking
causally increases coffee intake. Although the pattern of
results in the Mendelian randomization analysis was simi-
lar for tea consumption, we did not find clear evidence for
a causal effect of smoking heaviness on tea consumption.
In addition, we did not find evidence to support a causal
effect of coffee intake on daily cigarette consumption in
current smokers, suggesting that this may not be a bidirec-
tional effect.
Our findings from the Mendelian randomization ana-
lysis, that the smoking-increasing allele of rs16969968/
rs1051730 is positively associated with coffee intake in
current smokers, suggest that a causal effect of smoking on
coffee consumption could explain a large part of the obser-
vational association between smoking heaviness and coffee
consumption. The magnitude of the association in the
genetic analysis (0.16 additional cups of coffee per minor
allele) is similar, and in fact slightly larger than the obser-
vational association, given that the minor allele of this
variant is associated with smoking around one additional
cigarette per day.17 This may reflect measurement error in
the assessment of cigarettes per day, or the fact that
rs16969968 is a marker of total tobacco consumption
which is likely to vary even between individuals smoking
the same number of cigarettes, due to differences in the
way individuals smoke their cigarettes (e.g volume of
smoke inhaled).18,31 It is for this reason that we did not
perform a formal instrumental variable analysis of the ef-
fect of cigarettes smoked per day and coffee and tea con-
sumption. As discussed previously in relation to Mendelian
randomization studies of tobacco, use of a measured ex-
posure which does not fully capture the exposure deter-
mined by the genetic variant is a violation of the exclusion
restriction assumption of instrumental variable analysis,
and can lead to biased estimates of the magnitude of ef-
fects.32,33 To put the magnitude of the smoking heaviness
effect reported here into context, the size of the associ-
ation between rs16969968 and coffee consumption in cur-
rent smokers is similar to that observed for the most
strongly associated SNPs identified in GWAS of coffee
consumption.19,21,34
Lack of association of rs16969968/rs1051730 with cof-
fee consumption in never smokers provides us with some
evidence that this association is not due to pleiotropic ef-
fects of the variant (i.e. associations with the outcome not
via the exposure of interest). Furthermore, this finding is
strengthened by its consistency across studies from coun-
tries with different patterns of coffee consumption. The
small positive association observed in former smokers in
HUNT and CGPS suggests that there may be some residual
effect that persists following smoking cessation. The rea-
son for a lack of association in former smokers in UK
Biobank is unclear; it is possible that time since quitting in
UK Biobank is longer than in the other studies, as the
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sample is restricted to older individuals. We also repeated
analyses in the UK Biobank excluding occasional past
smokers (as UK Biobank has a high proportion of occa-
sional smokers) but this did not substantially alter the
association.
There are two key mechanisms through which smoking
may increase coffee consumption. First, it is well known
that cigarette smoke increases activity of the caffeine
metabolizing enzyme CYP1A2. Polycyclic aromatic hydro-
carbons in tobacco smoke bind to the aryl hydrocarbon
receptor, which activates the CYP1A2 gene.8 Faster metab-
olism of caffeine in smokers35,36 would require them to
consume more caffeine to experience its stimulating effects
and avoid withdrawal, but would also allow them to con-
sume higher levels before experiencing symptoms of caf-
feine toxicity.37 Second, the association may be due to
behavioural links between smoking and coffee consump-
tion, with smoking acting as a cue or providing an oppor-
tunity (i.e. a cigarette break) to consume coffee.1 The
association of rs16969968 with consumption of decaffei-
nated coffee in current smokers in UK Biobank offers some
support for this behavioural explanation. It is likely that
decaffeinated coffee consumers were once caffeinated cof-
fee consumers, so this could just reflect continuation of an
established behaviour. However, as UK Biobank partici-
pants were only able to indicate their main type of coffee
consumption in the questionnaire, it is likely that at least
some of the coffee consumption in this ‘decaffeinated’ ana-
lysis is caffeinated. Furthermore, the lack of clear evidence
for an association with tea suggests that the coffee-
smoking association is unlikely to be entirely behavioural.
Given the effect of tobacco smoke on caffeine metabol-
ism, it is perhaps surprising that we did not find clear evi-
dence for an association with tea consumption. It is
possible that the effect of smoking is limited to coffee; the
literature on the association between smoking and tea
drinking is less consistent than with coffee drinking, with
some studies finding positive2 and others null or negative
associations.1,2,38 However, this could simply reflect cul-
tural differences in tea consumption between the countries
in this analysis; in UK Biobank, which has the highest tea
consumption of all the studies, there was suggestive evi-
dence for a causal effect of smoking on tea consumption.
Interestingly, the effect size in UK Biobank was around
half of that observed for coffee, which might be expected
given the lower caffeine content of tea (typically around
half that of coffee).2 We were also unable to distinguish be-
tween caffeinated and decaffeinated tea consumption in
any of the studies; if the association is due to effects of
smoking on caffeine metabolism, including decaffeinated
tea would have weakened associations. Heavier smoking
may cause individuals to preferentially drink coffee rather
than tea due to its higher caffeine content.39 Analyses of
coffee and tea preference (Supplementary Figures 8 and 9),
and the negative association between the minor allele of
rs16969968/rs1051730 and consumption of any tea, sug-
gest that this might be the case. Therefore, lack of associ-
ation with tea consumption in this analysis may reflect
lower statistical power to detect smaller associations with
tea, cultural differences in tea consumption, or masking of
associations by preference for coffee.
Our analysis, along with previously published analyses
including GWAS data and data from the UK Biobank,24
did not find evidence that coffee consumption causally in-
creases smoking heaviness among smokers. The rs4410790
and rs2472297 SNPs are in or near genes involved in caf-
feine metabolism (CYP1A2 and AHR) and have also been
shown to associate with tea consumption.40 Therefore,
lack of association can be taken more broadly as evidence
that increased caffeine consumption may not cause
increased cigarette consumption. However, it is likely that
this analysis was underpowered, so we cannot rule out the
possibility of a causal effect in this direction.
There are several limitations to this analysis. First, the
UK Biobank had a response rate of around 5% and is not
very representative of individuals of this age group in the
UK. Our results could be affected by collider bias if selection
into the sample is related to both coffee consumption and
smoking.41 However, the consistency of the result for coffee
consumption with that seen in HUNT and CGPS, which
have higher response rates and are more likely to be repre-
sentative of the general population, suggest that this is un-
likely to be a major source of bias. Additionally, the UK
Biobank initial GWAS release contains about 50 000 indi-
viduals selected on the basis of smoking status and smoking
heaviness.42 However, exclusion of these individuals from
the UK Biobank analysis did not materially change results
(see Supplementary Figure S14). We also cannot rule out the
possibility that stratification by smoking status might induce
collider bias if the genetic variant itself determines smoking
status.43 Although rs16969968/rs1051730 is largely a deter-
minant of smoking heaviness within smokers17 and does not
appear to influence smoking initiation, there is evidence that
the minor allele is associated with being a current compared
with a former smoker.44
Tea and coffee consumption were self-reported and it is
likely that cup size and strength of coffee and tea dif-
fered between studies. We were also unable to evaluate as-
sociations with other potential sources of caffeine such
as cola or chocolate, because they were not available in
all studies. Therefore, magnitudes of effect should be
treated with caution, particularly if being used to make
inferences about the effect of smoking on caffeine
consumption.
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Misclassification of smoking status could be another
potential source of bias, but should serve to make estimates
of the association between rs16969968 and coffee con-
sumption in never, former and current smokers more simi-
lar to each other.
Last, we have only evaluated smoking heaviness in this
manuscript. The key genetic instrument for smoking initi-
ation in the BDNF gene is likely to be pleiotropic as it also
associates with other phenotypes, including coffee con-
sumption, at a genome-wide significance level.34
In conclusion, we provide evidence that higher cigarette
consumption increases coffee consumption, but not for a
causal effect in the opposite direction. These findings con-
firm the need to consider both coffee and smoking together
when considering the health implications of coffee or caf-
feine in population studies. In addition, given that it has
been hypothesized that overlap in symptoms between caf-
feine toxicity and nicotine withdrawal could increase risk
of relapse to smoking,45 our findings may have implica-
tions for smoking cessation if individuals trying to quit
smoking experience caffeine toxicity due to reduced caf-
feine metabolism.
Supplementary Data
Supplementary data are available at IJE online.
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